SCHEMBL10150690

SCHEMBL10150690

CC1CC/C=C/C[C@H](c2ccccc2)OC(=O)c2c(O)cc(O)c(Cl)c2CC(=O)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 4/20 0.52
STAT6 P42226 5/20 0.38
SMAD3 P84022 5/20 0.38
SMAD2 Q15796 5/20 0.38
MAPT P10636 4/20 0.38
HSP90AA1 P07900 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NLRP3 Q96P20 1/20 0.38
CBR1 P16152 1/20 0.38
PTGS2 P35354 1/20 0.38
ACLY P53396 1/20 0.38
FTO Q9C0B1 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10150085 0.90 HSP90AB1 (0.48) HSP90AB1STAT6SMAD3SMAD2MAPT
SCHEMBL10150022 0.88 HSP90AB1 (0.47) HSP90AB1STAT6SMAD3SMAD2MAPT
SCHEMBL10150021 0.81 HSP90AB1 (0.70) HSP90AB1STAT6SMAD3SMAD2MAPT
SCHEMBL10150018 0.81 HSP90AB1 (0.70) HSP90AB1STAT6SMAD3SMAD2MAPT
SCHEMBL19418251 0.80 HSP90AB1 (0.57) HSP90AB1STAT6SMAD3SMAD2MAPT
SCHEMBL19418258 0.79 HSP90AB1 (0.44) HSP90AB1STAT6SMAD3SMAD2MAPT
SCHEMBL19418043 0.78 HSP90AB1 (0.42) HSP90AB1MAPTMEN1KMT2AGAA
SCHEMBL10150079 0.77 HSP90AB1 (0.67) HSP90AB1STAT6SMAD3SMAD2MAPT
SCHEMBL13049717 0.77 HSP90AB1 (0.52) HSP90AB1STAT6SMAD3SMAD2MAPT
SCHEMBL12142596 0.75 HSP90AB1 (0.64) HSP90AB1STAT6SMAD3SMAD2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450305-B2 Macrocyclic compounds useful as inhibitors of kinases and HSP90 UNIVERSITE DE STRASBOURG (FR) 2013-05-28 US disclosed
US-20120077775-A1 MACROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF KINASES AND HSP90 LE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077775-A1 MACROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF KINASES AND HSP90 HSP90AB1, HSP90AA1, HSP90AB2P HSP90AB1 1/4885STAT6 3150/4885SMAD3 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.